Revenue growth reaccelerated to 48.1% in Q3 2026 with gross margins near 86.6%, yet operating margin of -43.9% and rising R&D and SG&A expenses suggest operating deleverage has not yet reversed.
Arteris, Inc. (AIP) annual income statement — 7-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 |
|---|
| Sales/Revenue | 92.98M | 70.58M | 57.72M | 53.67M | 50.38M | 37.86M | 31.81M | 31.5M |
| Revenue Growth % | 41.03% | 22.27% | 7.56% | 6.53% | 33.05% | 19.02% | 0.99% | - |
| Cost of Goods Sold | 12.81M | 6.89M | 5.96M | 5.08M | 4.28M | 3.73M | 1.49M | 1.86M |
| COGS % of Revenue | - | 9.77% | 10.33% | 9.46% | 8.5% | 9.85% | 4.69% | 5.91% |
| Gross Profit | 80.17M | 63.68M | 51.76M | 48.59M | 46.1M | 34.13M | 30.32M | 29.64M |
| Gross Margin % | 86.22% | 90.23% | 89.67% | 90.54% | 91.5% | 90.15% | 95.31% | 94.09% |
| Gross Profit Growth % | - | 23.03% | 6.53% | 5.41% | 35.05% | 12.57% | 2.3% | - |
| Operating Expenses | 122.57M | 96.82M | 83.36M | 83.73M | 74.95M | 55.9M | 34.1M | 22.37M |
| OpEx % of Revenue | - | 137.18% | 144.41% | 156.02% | 148.78% | 147.63% | 107.19% | 71% |
| Selling, General & Admin | 60M | 46.91M | 38.35M | 38.6M | 33.79M | 25.09M | 17.08M | 12.31M |
| SG&A % of Revenue | - | 66.47% | 66.44% | 71.93% | 67.06% | 66.25% | 53.68% | 39.09% |
| Research & Development | 60.88M | 49.91M | 45.01M | 45.13M | 41.17M | 30.81M | 17.02M | 10.05M |
| R&D % of Revenue | - | 70.71% | 77.97% | 84.09% | 81.72% | 81.38% | 53.5% | 31.91% |
| Other Operating Expenses | 475K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -42.41M | -33.14M | -31.6M | -35.14M | -28.86M | -21.77M | -3.78M | 7.27M |
| Operating Margin % | -45.61% | -46.95% | -54.74% | -65.48% | -57.28% | -57.48% | -11.87% | 23.09% |
| Operating Income Growth % | - | -4.88% | 10.09% | -21.78% | -32.58% | -476.25% | -151.93% | - |
| EBITDA | -37.23M | -29.76M | -28.23M | -32.07M | -26.76M | -20.27M | -2.84M | 8.03M |
| EBITDA Margin % | -40.04% | -42.17% | -48.91% | -59.76% | -53.11% | -53.54% | -8.93% | 25.49% |
| EBITDA Growth % | -31.31% | -5.41% | 11.97% | -19.87% | -31.98% | -613.34% | -135.4% | - |
| D&A (Non-Cash Add-back) | 5.18M | 3.38M | 3.36M | 3.07M | 2.1M | 1.49M | 935K | 756K |
| EBIT | -43.65M | -33.08M | -28.2M | -31.58M | -27.43M | -21.77M | -2.18M | 7.27M |
| Net Interest Income | -207K | -193K | -244K | -211K | 1.34M | -579K | -50K | -290K |
| Interest Income | 0 | 0 | 0 | 0 | 1.43M | 0 | 0 | 0 |
| Interest Expense | 207K | 193K | 244K | 211K | 89K | 579K | 50K | 290K |
| Other Income/Expense | -1.45M | -134K | 458K | -50K | 1.05M | -579K | 1.54M | -290K |
| Pretax Income | -43.86M | -33.27M | -31.14M | -35.19M | -27.8M | -22.34M | -2.23M | 6.98M |
| Pretax Margin % | -47.17% | -47.14% | -53.94% | -65.58% | -55.19% | -59.01% | -7.02% | 22.17% |
| Income Tax | -2.17M | 1.48M | 2.5M | 1.68M | -417K | 1.04M | 1.03M | 1.14M |
| Effective Tax Rate % | 4.96% | -4.43% | -8.03% | -4.77% | 1.5% | -4.65% | -45.93% | 16.38% |
| Net Income | -41.68M | -34.75M | -33.64M | -36.87M | -27.39M | -23.38M | -3.26M | 5.84M |
| Net Margin % | -44.83% | -49.23% | -58.27% | -68.7% | -54.36% | -61.76% | -10.25% | 18.54% |
| Net Income Growth % | -21.01% | -3.29% | 8.76% | -34.62% | -17.12% | -617.3% | -155.83% | - |
| Net Income (Continuing) | -41.68M | -34.75M | -33.64M | -36.87M | -27.39M | -23.38M | -3.26M | 5.84M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.84 | -0.82 | -0.86 | -1.03 | -0.84 | -1.06 | -0.10 | 0.21 |
| EPS Growth % | -7.23% | 4.65% | 16.5% | -22.62% | 20.75% | -960% | -147.62% | - |
| EPS (Basic) | - | -0.82 | -0.86 | -1.03 | -0.84 | -1.06 | -0.10 | 0.21 |
| Diluted Shares Outstanding | 49.38M | 42.29M | 38.91M | 35.68M | 32.58M | 21.97M | 31.53M | 22.05M |
| Basic Shares Outstanding | 49.38M | 42.29M | 38.91M | 35.68M | 32.58M | 21.97M | 31.53M | 22.05M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
Quick answers to the most common questions about buying AIP stock.
For fiscal year 2025, Arteris, Inc. (AIP) reported total revenue of $70.6M. This represents a 124.1% increase compared to $31.5M in 2019.
Arteris, Inc. (AIP) reported a net loss of $34.7M for the fiscal year ending 2025.
Arteris, Inc. (AIP) reported an operating income of $-33.1M, resulting in an operating profit margin of -47.0%. This margin reflects the operational efficiency of the business before interest and taxes.
Arteris, Inc. (AIP) generated $63.7M in gross profit for the year, representing a gross profit margin of 90.2%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Cash runway versus operating losses
Metrics are mathematically derived from official filings.
Revenue Growth Re-Accelerating Across Quarters
According to the reported quarterly income statement, Arteris revenue rose from $14.6M in Q2 2024 to $25.8M in Q3 2026, with year-over-year growth reaching 48.1% in the latest quarter, a notable reacceleration from the flat readings seen in early 2024.
The sequence suggests growth has strengthened rather than merely stabilized, with the step-up in the most recent quarters pointing toward design-win conversion in custom AI accelerator and automotive programs. Investors should distinguish between licensing-driven upfront revenue, which is lumpy under ASC 606, and royalty-driven recurring revenue, since the reported figures do not separate the two and the quarterly pattern may partly reflect timing of large license recognitions. Sustainability depends on whether royalty streams begin to contribute meaningfully as prior designs enter production.
High Gross Margin Masks Structural Operating Gap
Based on reported figures, Arteris maintained gross margins between roughly 83% and 91% across the ten quarters, yet operating margin remained deeply negative, ranging from -38.0% to -57.6%, indicating that the IP licensing model's margin profile has not yet translated into operating profitability.
A gross margin in the high 80s confirms the economics of an IP business with negligible cost of revenue, so the operating deficit reflects the cost of the R&D and customer-integration engineering base rather than any erosion in pricing. The modest quarter-to-quarter variation in gross margin, including the dip to 83.0% in Q1 2026, suggests mix effects rather than structural pressure. Expansion of operating margin would require revenue growth to outpace headcount growth, which the current data does not yet demonstrate.
Operating Deleverage Despite Revenue Scaling
As reported in the quarterly statements, R&D expense climbed from $10.7M to $16.4M and SG&A from $9.8M to $17.1M between Q2 2024 and Q3 2026, meaning operating expenses grew faster than the revenue base over the period under review.
Operating income did not improve in dollar terms, with the Q3 2026 loss of $11.3M compared with a $7.4M loss in Q2 2024, which suggests the company is currently reinvesting revenue gains into the cost base instead of converting them into operating leverage. This pattern warrants further investigation into whether the spending increases reflect durable growth investment or a cost structure that is outpacing realistic revenue ramps. The near-term test is whether the Q3 2026 revenue acceleration produces a narrowing of the operating loss in subsequent quarters.
Stock Compensation Heavy in Reported Losses
Based on reported figures, stock-based compensation of $4.6M in Q4 2025 and $5.5M in Q1 2026 represents a material share of the quarterly operating loss, and the $6.3M charge in Q2 2026 exceeded the quarter's entire net loss of $14.1M in proportion terms.
The magnitude of stock compensation relative to the operating loss means the reported GAAP deficit substantially overstates the cash economics of the business, though the cash-burn figure itself is not disclosed in the supplied data. Investors may wish to adjust for SBC when assessing the true operating burn rate, while recognizing that equity-based pay carries dilution costs. The data does not disclose tax anomalies or non-operating items, so those factors cannot be assessed here.
Path to Profitability Remains Unproven
Counter-analysis of reported figures suggests that Arteris has posted negative net income in every one of the ten quarters shown, with the Q3 2026 net margin of -43.3% offering no evidence yet of the operating leverage required to reach breakeven.
A bearish reading would emphasize that revenue growth alone has not closed the gap, since expense growth in R&D and SG&A has kept pace with or exceeded top-line gains, and the EPS miss in the latest quarter alongside unchanged guidance could be read as an early signal of cost discipline lagging. Concentration in Asia-Pacific customers and exposure to US-China export restrictions may also cap the licensing pipeline in ways the reported figures do not fully reveal. Investors should monitor whether operating margin improves materially from the reported -43.9% level within the next several quarters.